Suitable include Caprylocaproyl polyoxylglycerides, Lauroyl polyoxylglycerides, Linoleoyl polyoxylglycerides, Oleoyl polyoxylglycerides, Stearoyl polyoxylglycerides
None of them has undergone the kind of large-scale trials to establish safety and effectiveness that are required for FDA drug approvals
Conversely, if nausea, vomiting, or gastrointestinal distress limits your food intake to dangerously low levels on a low dose, that's a sign your body is over-responding, and dose reduction may be necessary
Both medications work by decelerating the digestive process, making gastrointestinal disturbances somewhat expected
The nasal delivery of metoclopramide offers a distinct advantage for patients with delayed gastric emptying, ensuring they receive the relief they need without the complications or unknown absorption associated with oral medications." EVERSANA was named Evokes commercialization partner to support commercialization efforts of GIMOTI, first in 2020 and then an extended partnership was announced in February 2022
